New fertility shot studied for women over 35
NCT ID NCT07553728
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at a fertility drug called corifollitropin alfa in women aged 36 to 40 who are doing IVF. The goal is to see if the drug is safe and helps produce eggs. Researchers will track side effects and pregnancy rates over one year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 'Abnormal' embryos still lead to healthy pregnancies? a new registry investigates
- Building a biological treasure trove to decode Women's health mysteries
- Can a sperm 'Quality Check' boost IVF success?
- Foam ultrasound for fertility checks: will women find it comfortable?
- A Hormone's hidden power: could progesterone be the key to unexplained infertility?
- A questionnaire to empower fertility patients — a pilot study puts it to the test